Clinical Trial Update: N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial update on N-803 for patients with progressive synovial sarcoma and myxoid/round cell liposarcoma who previously received adoptive cellular thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myxoid Liposarcoma
• Round Cell Liposarcoma
• Synovial Sarcoma

Drugs mentioned

• N-803

Snippet

Sponsor: Northwestern University | Conditions: Myxoid Liposarcoma, Round Cell Liposarcoma | EARLY_Phase 1 | Status: NOT_YET_RECRUITING